These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 837261)

  • 21. Investigative approach to the muscular dystrophies.
    Engel WK
    Adv Neurol; 1977; 17():197-226. PubMed ID: 888736
    [No Abstract]   [Full Text] [Related]  

  • 22. [Radioimmunoassay and immunohistochemical study of myoglobin in neuromuscular diseases].
    Liu Y
    Zhonghua Yi Xue Za Zhi; 1992 Mar; 72(3):144-6, 190. PubMed ID: 1319805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and pathological phenotype of the original family with Charcot-Marie-Tooth type 1B: a 20-year study.
    Bird TD; Kraft GH; Lipe HP; Kenney KL; Sumi SM
    Ann Neurol; 1997 Apr; 41(4):463-9. PubMed ID: 9124803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reinnervation in Duchenne muscular dystrophy.
    Dubrovsky A; Taratuto AL
    Muscle Nerve; 1983 May; 6(4):299-302. PubMed ID: 6866009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurophysiology and molecular genetics of Charcot-Marie-Tooth type 1 neuropathy in Croatian children: follow-up study.
    Barisić N; Mihatov I
    Croat Med J; 2000 Sep; 41(3):306-13. PubMed ID: 10962051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of muscle wasting in myotonic dystrophy.
    Griggs RC; Jozefowicz R; Kingston W; Nair KS; Herr BE; Halliday D
    Ann Neurol; 1990 May; 27(5):505-12. PubMed ID: 2360792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles.
    Gallardo E; García A; Combarros O; Berciano J
    Brain; 2006 Feb; 129(Pt 2):426-37. PubMed ID: 16317020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Visual, auditory and somatosensory pathway involvement in Charcot-Marie-Tooth disease].
    Tang XF; Werner T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Oct; 6(5):357-62. PubMed ID: 6241088
    [No Abstract]   [Full Text] [Related]  

  • 29. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A.
    Yoshikawa H; Nishimura T; Nakatsuji Y; Fujimura H; Himoro M; Hayasaka K; Sakoda S; Yanagihara T
    Ann Neurol; 1994 Apr; 35(4):445-50. PubMed ID: 7512319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Charcot-Marie-Tooth disease. Peroneal muscular atrophy].
    Hagen T; Jensen D; Dietrichson P; Heiberg A
    Tidsskr Nor Laegeforen; 1990 Oct; 110(24):3110-5. PubMed ID: 2237866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Motor unit number estimate of distal and proximal muscles in Charcot-Marie-Tooth disease.
    Lewis RA; Li J; Fuerst DR; Shy ME; Krajewski K
    Muscle Nerve; 2003 Aug; 28(2):161-7. PubMed ID: 12872319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Plasma alpha/beta lipoprotein coefficient in the diagnosis of progressive muscular dystrophy].
    Islamova IB
    Lab Delo; 1989; (10):34-5. PubMed ID: 2481069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infantile motor neuron diseases.
    Pearn JH
    Adv Neurol; 1982; 36():121-30. PubMed ID: 7180678
    [No Abstract]   [Full Text] [Related]  

  • 34. Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy.
    Yamazaki M; Minota S; Sakurai H; Miyazono K; Yamada A; Kanazawa I; Kawai M
    Am J Pathol; 1994 Feb; 144(2):221-6. PubMed ID: 8311110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory muscle weakness in Charcot-Marie-Tooth disease. A field study.
    Nathanson BN; Yu DG; Chan CK
    Arch Intern Med; 1989 Jun; 149(6):1389-91. PubMed ID: 2730255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motor axon loss is associated with hand dysfunction in Charcot-Marie-Tooth disease 1a.
    Videler AJ; van Dijk JP; Beelen A; de Visser M; Nollet F; van Schaik IN
    Neurology; 2008 Oct; 71(16):1254-60. PubMed ID: 18852440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Characteristics of carbohydrate-phosphorus and electrolyte metabolism in the erythrocytes of patients with progressive muscular dystrophy and in their closest relations].
    Degtiar VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(3):333-41. PubMed ID: 4466265
    [No Abstract]   [Full Text] [Related]  

  • 38. Value of immunohistochemical investigation in the diagnosis of neuromuscular diseases in children.
    Matei D; Gherghina I; Cinteză E; Matei A; Alexianu M
    Rom J Morphol Embryol; 2011; 52(1):111-5. PubMed ID: 21424041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium channel and sodium pump in normal and pathological muscles from patients with myotonic muscular dystrophy and lower motor neuron impairment.
    Desnuelle C; Lombet A; Serratrice G; Lazdunski M
    J Clin Invest; 1982 Feb; 69(2):358-67. PubMed ID: 6276440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Electron microscopic study of the T-system in progressive muscular dystrophy and other neuromuscular diseases (author's transl)].
    Oguchi K; Tsukagoshi H
    Rinsho Shinkeigaku; 1978 May; 18(5):266-72. PubMed ID: 699433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.